ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668259 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668259; 2) Community: the network communities that were significantly associated with the response to NSC 668259; 3) Molecule: the relationships between components within communities and NSC 668259; 4) MDR: the compounds that were significantly associated with the NSC 668259.

NSC Compound Enrichment Correlation
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0378615809326463 0.14065109
NSC 244404 Null 0.0378615809326463 0.28268259
NSC 300289 Pinafide 0.0378615809326463 0.06495622
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0378615809326463 0.50552813
NSC 33570 Null 0.0378615809326463 0.38722739
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0378615809326463 0.24795011
NSC 42972 Null 0.0378615809326463 0.5038969
NSC 55236 Null 0.0378615809326463 0.44208902
NSC 606497 Camptothecin Derivative 0.0378615809326463 -0.026831833
NSC 629229 Null 0.0378615809326463 0.24865007
Total:113  Current:90    [First] [Prev] [Next] [Last]